Langar Investment Management Shifts LGHT ETF to Cboe BZX Exchange

Langar Investment Management Transfers LGHT ETF to Cboe BZX

On July 7, 2026, Langar Investment Management LLC officially announced that it will be transferring the primary listing of the Langar Global HealthTech ETF (ticker: LGHT) from NYSE Arca to the Cboe BZX Exchange. This move is scheduled to take place around June 29, 2026. Current shareholders of the LGHT fund will not need to take any action regarding this transition, as it is not expected to affect the trading dynamics of the Fund's shares.

The Langar Global HealthTech ETF, recognized as the first pure-play healthtech ETF, aims to foster long-term capital growth by investing primarily in companies that blend healthcare and technology. This includes segments such as digital health, medical devices, health data infrastructure, and AI-driven diagnostics.

Interestingly, despite the change in listing venue, the ETF's investment objectives, strategies, and management teams will remain unchanged. Investors can still expect the same level of management and investment strategy that the fund has consistently provided. This stability is crucial for shareholders who rely on LGHT's strategic positioning in the ever-growing health technology sector.

For those interested in the management behind the fund, Langar Investment Management serves as the investment management arm of Langar Technology, Inc. Their commitment has always been to reflect the pulse of the healthtech landscape, enabling investors to have targeted exposure to the progressive meetings of healthcare and technology.

In today's digital age, where health and technology intertwine more than ever, this ETF positions itself as a key facilitator for investors looking to tap into this burgeoning industry. The decision to move listings to the Cboe BZX Exchange could also enhance the liquidity and visibility of LGHT, potentially laying the groundwork for future growth.

For comprehensive information regarding the Langar Global HealthTech ETF, investors are directed to visit langarfunds.com. Here, additional details regarding the fund's objectives, strategies, and overall performance can be found, offering shareholders and potential investors a complete picture of what to expect moving forward.

Important Considerations

While the transition to a new exchange is promising, it is always important for investors to be aware of the inherent risks involved in investing. Such risks include potential capital loss and the performance volatility linked to stock trading. As with any investment, it’s recommended that investors conduct thorough research. The shares of the fund are traded at market price, not at net asset value (NAV) per share, and may fluctuate between trading at a premium or discount to NAV.

Conclusion

Indeed, the transfer of the LGHT ETF listing is a significant step for Langar Investment Management. It signals their confidence in the growth of the healthtech market and their commitment to providing robust investment opportunities within this dynamic sector. Investors looking to combine their passion for healthcare with investment might find this fund an attractive option. As the integration of healthcare and technology continues to evolve, the Langar Global HealthTech ETF stands as a bridge between progressive innovation and investment potential.